Fate of Antibody-Drug Conjugates in Cancer Cells

Antibody-Drug Conjugates (ADCs) are a class of cancer therapeutics that combines antigen specificity and potent cytotoxicity in a single molecule as they are comprised of an engineered antibody linked chemical...

from Cancer via ola Kala on Inoreader http://ift.tt/2nJ8VbT
via IFTTT